PBYI
Puma Biotechnology, Inc.$10.20-0.24 (-2.30%)Prev Close$10.44·MCap$544.1M·P/E17.06·Vol136.7K·Yield—
▲
Buys (12M)
0
$0.00
▼
Sells (12M)
14
$2.12M
◆
Net Activity
Net Seller
$2.12M
●
Active Insiders
10
last 12 mo
Over the past 12 months, insider activity at Puma Biotechnology, Inc. (PBYI) has been exclusively selling, with 0 insider purchases totaling $0.00 and 14 insider sales totaling $2.12M. The most recent insider transaction was by WILSON TROY EDWARD (director), who sold $45.5K worth of shares on Sep 16, 2026. Puma Biotechnology, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $544.1M.
PBYI Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Sep 16, 2026 | WILSON TROY EDWARD | director | Sell | 5,000 | $9.10 | $45.5K | 54,750 |
| Sep 16, 2026 | Cesano Alessandra | director | Sell | 62,150 | $9.12 | $567.0K | 56,700-52% |
| Jul 8, 2026 | HUNT DOUGLAS M | officer: See Remarks | Sell | 8,460 | $8.26 | $69.9K | 196,841 |
| Jul 8, 2026 | NOUGUES MAXIMO F | officer: Chief Financial Officer | Sell | 9,386 | $8.26 | $77.6K | 230,637 |
| Jul 8, 2026 | AUERBACH ALAN H | director, 10 percent owner, officer: President and CEO | Sell | 44,058 | $8.26 | $364.1K | 7,261,671 |
| Jun 15, 2026 | Dorval Allison | director | Sell | 11,610 | $7.20 | $83.6K | 90,780 |
| Jun 15, 2026 | WILSON TROY EDWARD | director | Sell | 10,800 | $7.20 | $77.7K | 59,750 |
| Jun 15, 2026 | Stuglik Brian M | director | Sell | 8,100 | $7.20 | $58.3K | 113,858 |
| Jun 15, 2026 | MOYES JAY M | director | Sell | 22,000 | $7.22 | $158.8K | 58,322-27% |
| Jun 15, 2026 | Senderowicz Adrian | director | Sell | 27,000 | $7.20 | $194.3K | 27,000-50% |
| Jan 8, 2026 | AUERBACH ALAN H | director, 10 percent owner, officer: President and CEO | Sell | 34,950 | $5.86 | $204.9K | 7,163,963 |
| Jan 8, 2026 | HUNT DOUGLAS M | officer: See Remarks | Sell | 8,987 | $5.86 | $52.7K | 160,921 |
| Jan 8, 2026 | NOUGUES MAXIMO F | officer: Chief Financial Officer | Sell | 10,945 | $5.86 | $64.2K | 199,689 |
| Nov 13, 2025 | MILLER MICHAEL PATRICK | Director | Sell | 20,000 | $4.86 | $97.2K | 54,000-27% |
| Jul 22, 2025 | Cesano Alessandra | Director | Sell | 27,000 | $3.37 | $90.9K | 41,850-39% |
| Jul 10, 2025 | AUERBACH ALAN H | President and CEO | Sell | 47,172 | $3.53 | $166.7K | 7,202,481 |
| Jul 10, 2025 | HUNT DOUGLAS M | See Remarks | Sell | 7,817 | $3.53 | $27.6K | 168,337 |
| Jul 10, 2025 | NOUGUES MAXIMO F | Chief Financial Officer | Sell | 9,522 | $3.53 | $33.6K | 208,164 |
| Jun 17, 2025 | Cesano Alessandra | Director | Sell | 12,150 | $3.40 | $41.3K | 68,850 |
| Jun 17, 2025 | Dorval Allison | Director | Sell | 11,610 | $3.40 | $39.5K | 75,390 |
| Jun 17, 2025 | MOYES JAY M | Director | Sell | 22,000 | $3.40 | $74.8K | 53,322-29% |
| Jun 17, 2025 | Senderowicz Adrian | Director | Sell | 27,000 | $3.40 | $91.8K | 27,000-50% |
| Jun 17, 2025 | Stuglik Brian M | Director | Sell | 8,100 | $3.39 | $27.5K | 94,958 |
| Jun 17, 2025 | WILSON TROY EDWARD | Director | Sell | 10,800 | $3.40 | $36.7K | 43,550 |
| Jan 3, 2025 | AUERBACH ALAN H | President and CEO | Sell | 33,841 | $3.15 | $106.7K | 7,029,674 |
| Jan 3, 2025 | HUNT DOUGLAS M | See Remarks | Sell | 8,633 | $3.15 | $27.2K | 124,594 |
| Jan 3, 2025 | Ludwig Jeffrey Jerome | Chief Commercial Officer | Sell | 9,437 | $3.15 | $29.7K | 108,951 |
| Jan 3, 2025 | NOUGUES MAXIMO F | Chief Financial Officer | Sell | 10,227 | $3.15 | $32.2K | 152,295 |
| Aug 13, 2024 | MILLER MICHAEL PATRICK | Director | Sell | 23,358 | $3.49 | $81.5K | 47,000-33% |
| Jul 18, 2024 | AUERBACH ALAN H | President and CEO | Sell | 21,920 | $3.70 | $81.1K | 7,063,515 |
| Jul 18, 2024 | HUNT DOUGLAS M | See Remarks | Sell | 3,637 | $3.70 | $13.5K | 133,227 |
| Jul 18, 2024 | Ludwig Jeffrey Jerome | Chief Commercial Officer | Sell | 2,598 | $3.70 | $9.6K | 118,388 |
| Jul 18, 2024 | NOUGUES MAXIMO F | Chief Financial Officer | Sell | 4,156 | $3.70 | $15.4K | 162,522 |
| Jul 2, 2024 | AUERBACH ALAN H | President and CEO | Sell | 18,885 | $3.27 | $61.7K | 7,085,435 |
| Jul 2, 2024 | HUNT DOUGLAS M | See Remarks | Sell | 4,349 | $3.27 | $14.2K | 136,864 |
| Jul 2, 2024 | Ludwig Jeffrey Jerome | Chief Commercial Officer | Sell | 6,051 | $3.27 | $19.8K | 120,986 |
| Jul 2, 2024 | NOUGUES MAXIMO F | Chief Financial Officer | Sell | 5,295 | $3.27 | $17.3K | 166,678 |
| Jun 17, 2024 | Dorval Allison | Director | Sell | 11,000 | $3.37 | $37.1K | 33,000-25% |
| Jun 17, 2024 | MOYES JAY M | Director | Sell | 22,000 | $3.34 | $73.5K | 21,322-51% |
| Jun 17, 2024 | Senderowicz Adrian | Director | Sell | 27,000 | $3.33 | $89.8K | 0Exit |
| Jun 17, 2024 | Stuglik Brian M | Director | Sell | 9,900 | $3.39 | $33.5K | 49,058 |
| Jun 17, 2024 | WILSON TROY EDWARD | Director | Sell | 27,000 | $3.33 | $89.9K | 350-99% |
| Jan 10, 2024 | Wong Alvin F | Chief Scientific Officer | Sell | 280 | $3.76 | $1.1K | 97,934 |
| Jan 5, 2024 | AUERBACH ALAN H | President and CEO | Sell | 41,396 | $4.49 | $185.7K | 6,936,947 |
| Jan 5, 2024 | HUNT DOUGLAS M | See Remarks | Sell | 8,358 | $4.49 | $37.5K | 103,319 |
| Jan 5, 2024 | Ludwig Jeffrey Jerome | Chief Commercial Officer | Sell | 12,956 | $4.49 | $58.1K | 99,970 |
| Jan 5, 2024 | NOUGUES MAXIMO F | Chief Financial Officer | Sell | 15,682 | $4.49 | $70.3K | 128,666 |
| Jan 5, 2024 | Wong Alvin F | Chief Scientific Officer | Sell | 7,733 | $4.49 | $34.7K | 98,214 |
| Nov 9, 2023 | MILLER MICHAEL PATRICK | Director | Sell | 25,000 | $2.83 | $70.8K | 43,358-37% |
| Jul 6, 2023 | AUERBACH ALAN H | President and CEO | Sell | 60,698 | $3.31 | $201.0K | 6,978,343 |
Showing 1–50 of 149
1 / 3
PBYI Insider Buying Activity
The following table shows recent insider purchases of Puma Biotechnology, Inc. (PBYI) stock reported via SEC Form 4 filings.
No insider buying activity found for PBYI in the last 12 months.
PBYI Insider Selling Activity
The following table shows recent insider sales of Puma Biotechnology, Inc. (PBYI) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Sep 16, 2026 | WILSON TROY EDWARD | director | Sell | 5,000 | $9.10 | $45.5K | 54,750 |
| Sep 16, 2026 | Cesano Alessandra | director | Sell | 62,150 | $9.12 | $567.0K | 56,700-52% |
| Jul 8, 2026 | HUNT DOUGLAS M | officer: See Remarks | Sell | 8,460 | $8.26 | $69.9K | 196,841 |
| Jul 8, 2026 | NOUGUES MAXIMO F | officer: Chief Financial Officer | Sell | 9,386 | $8.26 | $77.6K | 230,637 |
| Jul 8, 2026 | AUERBACH ALAN H | director, 10 percent owner, officer: President and CEO | Sell | 44,058 | $8.26 | $364.1K | 7,261,671 |
| Jun 15, 2026 | Dorval Allison | director | Sell | 11,610 | $7.20 | $83.6K | 90,780 |
| Jun 15, 2026 | WILSON TROY EDWARD | director | Sell | 10,800 | $7.20 | $77.7K | 59,750 |
| Jun 15, 2026 | Stuglik Brian M | director | Sell | 8,100 | $7.20 | $58.3K | 113,858 |
| Jun 15, 2026 | MOYES JAY M | director | Sell | 22,000 | $7.22 | $158.8K | 58,322-27% |
| Jun 15, 2026 | Senderowicz Adrian | director | Sell | 27,000 | $7.20 | $194.3K | 27,000-50% |
| Jan 8, 2026 | AUERBACH ALAN H | director, 10 percent owner, officer: President and CEO | Sell | 34,950 | $5.86 | $204.9K | 7,163,963 |
| Jan 8, 2026 | HUNT DOUGLAS M | officer: See Remarks | Sell | 8,987 | $5.86 | $52.7K | 160,921 |
| Jan 8, 2026 | NOUGUES MAXIMO F | officer: Chief Financial Officer | Sell | 10,945 | $5.86 | $64.2K | 199,689 |
| Nov 13, 2025 | MILLER MICHAEL PATRICK | Director | Sell | 20,000 | $4.86 | $97.2K | 54,000-27% |
| Jul 22, 2025 | Cesano Alessandra | Director | Sell | 27,000 | $3.37 | $90.9K | 41,850-39% |
| Jul 10, 2025 | AUERBACH ALAN H | President and CEO | Sell | 47,172 | $3.53 | $166.7K | 7,202,481 |
| Jul 10, 2025 | HUNT DOUGLAS M | See Remarks | Sell | 7,817 | $3.53 | $27.6K | 168,337 |
| Jul 10, 2025 | NOUGUES MAXIMO F | Chief Financial Officer | Sell | 9,522 | $3.53 | $33.6K | 208,164 |
| Jun 17, 2025 | Cesano Alessandra | Director | Sell | 12,150 | $3.40 | $41.3K | 68,850 |
| Jun 17, 2025 | Dorval Allison | Director | Sell | 11,610 | $3.40 | $39.5K | 75,390 |
| Jun 17, 2025 | MOYES JAY M | Director | Sell | 22,000 | $3.40 | $74.8K | 53,322-29% |
| Jun 17, 2025 | Senderowicz Adrian | Director | Sell | 27,000 | $3.40 | $91.8K | 27,000-50% |
| Jun 17, 2025 | Stuglik Brian M | Director | Sell | 8,100 | $3.39 | $27.5K | 94,958 |
| Jun 17, 2025 | WILSON TROY EDWARD | Director | Sell | 10,800 | $3.40 | $36.7K | 43,550 |
| Jan 3, 2025 | AUERBACH ALAN H | President and CEO | Sell | 33,841 | $3.15 | $106.7K | 7,029,674 |
| Jan 3, 2025 | HUNT DOUGLAS M | See Remarks | Sell | 8,633 | $3.15 | $27.2K | 124,594 |
| Jan 3, 2025 | Ludwig Jeffrey Jerome | Chief Commercial Officer | Sell | 9,437 | $3.15 | $29.7K | 108,951 |
| Jan 3, 2025 | NOUGUES MAXIMO F | Chief Financial Officer | Sell | 10,227 | $3.15 | $32.2K | 152,295 |
| Aug 13, 2024 | MILLER MICHAEL PATRICK | Director | Sell | 23,358 | $3.49 | $81.5K | 47,000-33% |
| Jul 18, 2024 | AUERBACH ALAN H | President and CEO | Sell | 21,920 | $3.70 | $81.1K | 7,063,515 |
| Jul 18, 2024 | HUNT DOUGLAS M | See Remarks | Sell | 3,637 | $3.70 | $13.5K | 133,227 |
| Jul 18, 2024 | Ludwig Jeffrey Jerome | Chief Commercial Officer | Sell | 2,598 | $3.70 | $9.6K | 118,388 |
| Jul 18, 2024 | NOUGUES MAXIMO F | Chief Financial Officer | Sell | 4,156 | $3.70 | $15.4K | 162,522 |
| Jul 2, 2024 | AUERBACH ALAN H | President and CEO | Sell | 18,885 | $3.27 | $61.7K | 7,085,435 |
| Jul 2, 2024 | HUNT DOUGLAS M | See Remarks | Sell | 4,349 | $3.27 | $14.2K | 136,864 |
| Jul 2, 2024 | Ludwig Jeffrey Jerome | Chief Commercial Officer | Sell | 6,051 | $3.27 | $19.8K | 120,986 |
| Jul 2, 2024 | NOUGUES MAXIMO F | Chief Financial Officer | Sell | 5,295 | $3.27 | $17.3K | 166,678 |
| Jun 17, 2024 | Dorval Allison | Director | Sell | 11,000 | $3.37 | $37.1K | 33,000-25% |
| Jun 17, 2024 | MOYES JAY M | Director | Sell | 22,000 | $3.34 | $73.5K | 21,322-51% |
| Jun 17, 2024 | Senderowicz Adrian | Director | Sell | 27,000 | $3.33 | $89.8K | 0Exit |
| Jun 17, 2024 | Stuglik Brian M | Director | Sell | 9,900 | $3.39 | $33.5K | 49,058 |
| Jun 17, 2024 | WILSON TROY EDWARD | Director | Sell | 27,000 | $3.33 | $89.9K | 350-99% |
| Jan 10, 2024 | Wong Alvin F | Chief Scientific Officer | Sell | 280 | $3.76 | $1.1K | 97,934 |
| Jan 5, 2024 | AUERBACH ALAN H | President and CEO | Sell | 41,396 | $4.49 | $185.7K | 6,936,947 |
| Jan 5, 2024 | HUNT DOUGLAS M | See Remarks | Sell | 8,358 | $4.49 | $37.5K | 103,319 |
| Jan 5, 2024 | Ludwig Jeffrey Jerome | Chief Commercial Officer | Sell | 12,956 | $4.49 | $58.1K | 99,970 |
| Jan 5, 2024 | NOUGUES MAXIMO F | Chief Financial Officer | Sell | 15,682 | $4.49 | $70.3K | 128,666 |
| Jan 5, 2024 | Wong Alvin F | Chief Scientific Officer | Sell | 7,733 | $4.49 | $34.7K | 98,214 |
| Nov 9, 2023 | MILLER MICHAEL PATRICK | Director | Sell | 25,000 | $2.83 | $70.8K | 43,358-37% |
| Jul 6, 2023 | AUERBACH ALAN H | President and CEO | Sell | 60,698 | $3.31 | $201.0K | 6,978,343 |
PBYI Insiders
Similar Stocks to PBYI
MRNA
Moderna, Inc.
$226.63+2.24%
$85.50B
REGN
Regeneron Pharmaceuticals, Inc.
$967.25+4.30%
$83.15B
RVMD
Revolution Medicines, Inc.
$189.50-0.95%
$39.42B
ALNY
Alnylam Pharmaceuticals, Inc.
$161.40-2.21%
$30.46B
UTHR
United Therapeutics Corporation
$596.00-0.45%
$25.15B
INCY
Incyte Corporation
$119.18-0.92%
$23.69B
INSM
Insmed Incorporated
$110.41-1.93%
$21.18B
EXEL
Exelixis, Inc.
$71.86+3.59%
$16.64B